{"nct_id":"NCT05769777","title":"Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-04-03","start_date_type":"ACTUAL","primary_completion_date":"2031-06-11","primary_completion_date_type":"ESTIMATED","completion_date":"2031-06-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["SNY"]}